Skip to main content
Caplight Logo









Unlearn

Unlearn

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://unlearn.ai

Last Round

Series C

Feb 8, 2024

Est. Valuation

$265M

Total Funding Raised

$134.85M

Company Overview

Unlearn operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series C round in February 2024.

Unlearn is a healthcare technology company that develops an AI platform creating digital twins of clinical trial participants to enable smaller, faster, and more successful studies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Synthetic Data, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Unlearn Comparables

Compare Unlearn with similar companies based on industry and business-model similarity.

Unlearn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantHealth
84%
Nova In Silico
81%
PhaseV
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Unlearn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 8, 2024
Early FundingMar 22, 2023
Series BApr 19, 2022
Series A ExtensionNov 5, 2020
Series AApr 20, 2020
Seed
Jul 12, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Steven Herne

Chief Executive Officer

Executive Team

Jack J. McGovern

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Unlearn Investors

Notable investors and investment history

Unlearn investors
InvestorRounds
Human CapitalSeries B
DCVC BioSeries A, Series C, Series B, Seed
Founders FundSeries A, Series B
Global VenturesSeries B
Necessary VenturesSeries C
EPIC VenturesSeries A, Series C, Series A Extension
Mubadala CapitalSeed, Series A, Series C, Series B
Book a demo to see all 16 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    Announced the release of AD DTG 4.2, an Alzheimer's disease Digital Twin Generator update.

  • Feb 12, 2026

    Partnering with VectorY Therapeutics for PIONEER-ALS study using digital twins.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withNov 12, 2026

    Unlearn.ai, Inc. and Structure Therapeutics, Inc. collaborate in California on Nov 12th '26 to analyze data from Structure Therapeutics' completed ACCESS open-label extension study and explore AI-generated digital twins in obesity research.

Book a demo to see all news

For institutional investors. Book with your work email.

Unlearn Filings

Explore SEC and related filing metadata, where available.

Unlearn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Unlearn's valuation, stock price, and market status.

Is Unlearn a public or private company?

Unlearn is a private company.

What is the current stock price of Unlearn?

Unlearn is a private company, so its shares have no public market price. Caplight tracks Unlearn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Unlearn worth (valuation)?

Unlearn's valuation is estimated at $265.0M based on funding round data.

Can I buy Unlearn stock?

Unlearn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Unlearn's last funding round?

Unlearn's most recent funding round was Series C on February 8, 2024.

Who are the main investors in Unlearn?

Key investors in Unlearn include DCVC Bio, Global Ventures, EPIC Ventures, Wittington Ventures, 8VC.

Will Unlearn IPO soon?

No public IPO plans have been announced for Unlearn.

How can I track Unlearn secondary market activity?

Caplight tracks bids, offers, and trades in Unlearn's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range59
Year Founded2017
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?